COMMUNIQUÉS West-GlobeNewswire

Alignment Healthcare to Present in Baird 2026 Global Healthcare Conference and Attend Morgan Stanley 24th Annual Global Healthcare Conference
20/08/2026
ORANGE, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will participate in and attend two upcoming healthcare conferences in New York: Presenting: Baird 2026 [...]
Jushi Holdings Inc. Announces Opening of Relocated Beyond Hello™ Dispensary in Belle Vernon, Pennsylvania
20/08/2026
A Media Snippet accompanying this announcement is available by clicking on this link. BOCA RATON, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSH ) , a [...]
Frishantic Launches Berberine Supplement with Ceylon Cinnamon for Daily Wellness Routines
20/08/2026
New Formula Combines 500 mg Berberine Hydrochloride with Ceylon Cinnamon, Chromium, Alpha-Lipoic Acid, and BioPerine® NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Frishantic , a supplement brand focused on clean-label [...]
Baird Medical Expands Global Microwave Ablation Footprint with Additional Product Registrations in Pakistan
20/08/2026
Registrations cover the BD-GT Microwave Ablation System and T-1610 Disposable Microwave Ablation Needle NEW YORK, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) (“Baird Medical” [...]
Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference
20/08/2026
NEW HOPE, Pa., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk- [...]
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
20/08/2026
Debt and liabilities holders have executed $10.7 million of Series A Convertible Exchange Agreements; of which $4.57 million was converted into Series A Convertible Preferred Stock Sufficient working capital obtained to [...]
Sol-Gel Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
20/08/2026
Pivotal Phase 3 clinical trial of SGT-610 (patidegib gel, 2%) for Gorlin syndrome remains ongoing, with top-line results on track for anticipated readout in late November 2026 Sol-Gel has initiated a proof-of-concept [...]
RenovoRx Receives Notice of Allowance for New U.S. Patent Covering RenovoCath®, an Advanced Dual-Occlusion Catheter, for Targeted Therapeutic Drug-Delivery for Cancer Treatment
20/08/2026
As Commercial and Clinical Programs Advance, RenovoRx Continues to Strengthen its Global Intellectual Property Portfolio with 20 Issued or Allowed Patents and 13 Pending Patents to Support the Commercialization of [...]
Cannabix Technologies Deploys BreathLogix Alcohol System at Montana's Big Horn County Probation and Pre-Trial Services Department Under State's 24/7 Sobriety Program
20/08/2026
VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices, is pleased to announce the deployment of [...]
Artelo Biosciences Secures Notice of Allowance in Japan for Patent Claims for the Intended Commercial Formulation of ART27.13
20/08/2026
SOLANA BEACH, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) (“Artelo” or the “Company”) , a clinical-stage pharmaceutical company focused on modulating lipid-signalling pathways to [...]
Prenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership
20/08/2026
— Lily is IM8’s first Global Ambassador from film and television, extending a roster built in elite sport into global entertainment and culture — Lily brings a following of more than 33 million across social platforms [...]
INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International
20/08/2026
Research from Wisconsin Fertility Institute evaluates ovarian and subendometrial PRP in patients with prior poor IVF response and endometrial-development challenges SARASOTA, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- INVO [...]
New Study Demonstrates AliveCor’s KardiaMobile 6L Significantly Increases Arrhythmia Detection Beyond Traditional Ambulatory Monitoring
20/08/2026
Peer-reviewed research in JACC Advances reveals patient-initiated, symptom-triggered 6-lead ECG monitoring nearly doubles the diagnostic yield of conventional continuous monitoring modalities MOUNTAIN VIEW, Calif., Aug [...]
HealthEdge® Expands India Footprint with New Thiruvananthapuram Campus, Deepening Commitment to Technology Innovation and Growth in Kerala
20/08/2026
THIRUVANANTHAPURAM, India, Aug. 20, 2026 (GLOBE NEWSWIRE) -- HealthEdge ® , a leading healthcare technology company serving more than 110 million covered lives across the United States, today inaugurated its new campus [...]
Grey Matters Achieves Final Major Milestone; Receives Radioactive Materials License from State of Florida for its Flagship NovaScan Neuroimaging Clinics™ Location
20/08/2026
VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the “ Company” or “ Grey Matters ”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to [...]
Creative Medical Technology Holdings Successfully Completes Enrollment and Treatment Across Entire FDA-Cleared ADAPT Trial, Including Opioid Cohort, Advancing CELZ-201 / Olastrocel Toward RMAT Evaluation and Phase 3 Planning
20/08/2026
All patients enrolled and treated across original and FDA-cleared expansion cohorts Positive safety and early efficacy signals continue to support late-stage development planning for Olastrocel in chronic lower back [...]
BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026
20/08/2026
Pumitamig plus B7H3-targeting elfetabart drozuntecan delivers the first data in lung cancer for any PD-(L)1xVEGF bispecific immunomodulator combined with an antibody-drug conjugate, underscoring BioNTech’s leadership in [...]
Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement
20/08/2026
NANJING, China, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the full abstract of the Phase II clinical study evaluating [...]
Zelluna ASA: Second Quarter 2026 results
20/08/2026
Oslo, 20 August 2026 – Zelluna (OSE: ZLNA), a clinical-stage company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today presents [...]

Pages